A carregar...
Inhibition of EZH2 enhances the antitumor efficacy of metformin in prostate cancer
Upregulation of EZH2 is associated with advanced stage and poor prognosis of PCa, it is therefore likely to be a promising therapeutic target. Metformin, a drug that has been used to treat type II diabetes, was found to have anti-neoplastic activity in different cancers. Herein, we report that the c...
Na minha lista:
| Publicado no: | Mol Cancer Ther |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7718407/ https://ncbi.nlm.nih.gov/pubmed/33024029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-19-0874 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|